Dennis Ding

Stock Analyst at Jefferies

(0)
# 5129
Out of 5,441 analysts
20
Total ratings
Success rate
Average return
17 Stocks
Name Action PT Current % Upside Ratings Updated
INDV Indivior
Assumes: Buy
20
22.3 -10.31% 1 Jul 22, 2025
MLYS Mineralys Therapeuti...
Initiates Coverage On: Hold
15 15
13.2 13.64% 1 Jun 11, 2025
CRNX Crinetics Pharmaceut...
Upgrades: Buy
55
27.39 100.8% 1 Jan 22, 2025
IKT Inhibikase Therapeut...
Initiates Coverage On: Buy
8
1.51 429.8% 1 Nov 8, 2024
ASMB Assembly Biosciences
Upgrades: Buy
2 35
23.54 48.68% 1 Sep 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
6.66 170.27% 1 Sep 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
5 7
3.34 109.58% 2 Sep 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
8 6
5.29 13.42% 1 Sep 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
500 25
6.67 274.81% 1 May 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
648
5.32 12080.45% 1 Jun 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
35 22
71.95 -69.42% 1 Feb 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
24.4 -1.64% 1 Dec 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Oct 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
30
29.06 3.23% 1 Feb 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
2.18 1046.79% 1 Jan 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
195 52
22.47 131.42% 2 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
11.18 -10.55% 1 Oct 26, 2021